Completed

Battery Powered Bion Clinical Investigation: An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

bion

Device
Who is being recruted

Urogenital Diseases+7

+ Female Urogenital Diseases and Pregnancy Complications

+ Urinary Incontinence

Over 18 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Placebo-ControlledPhase 3
Interventional
Study Start: June 2003
See protocol details

Summary

Principal SponsorBoston Scientific Corporation
Last updated: January 13, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: June 1, 2003

Actual date on which the first participant was enrolled.

This clinical trial is being conducted to investigate the safety and effectiveness of a new device designed to treat urinary urge incontinence in those patients who have tried and failed two or more conservative therapies.

Official TitleBattery Powered Bion Clinical Investigation: An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence 
NCT00080470
Principal SponsorBoston Scientific Corporation
Last updated: January 13, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

148 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrinary IncontinenceUrination DisordersUrologic DiseasesUrological ManifestationsFemale Urogenital DiseasesMale Urogenital DiseasesUrinary Incontinence, UrgeLower Urinary Tract Symptoms

Criteria

Key Inclusion Criteria: 1. Age 18 years and above. 2. Diagnosed with urinary urge incontinence. 3. Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor. 4. Have normal upper urinary tract function. 5. Be capable of giving informed consent. 6. Be capable and willing to follow all study related procedures. Key Exclusion Criteria: 1. Have any active implantable device regardless of whether stimulation status is ON or OFF. 2. Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 months period. 3. Less than one year post partum and/or are breast-feeding. 4. Have any passive implant that contains metal or electrically conductive materials. 5. Have conditions requiring Magnetic Resonance Imaging (MRI) evaluation. 6. Have conditions requiring diathermy procedures. 7. Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver. 8. Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes. 9. Have history of coagulopathy or bleeding disorder. 10. Have a history of pelvic pain as primary diagnosis. 11. Have anatomical restrictions such that the study device placement is not possible. 12. Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function. 13. Have a life expectancy of less than 1 year. 14. Cannot independently comprehend and complete the QoL questionnaires.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental
Stimulation On from Initial Activation up to the 12 month post-activation. Stimulation Off from 12 months post-activation until 45 days after the 12 month visit. Stimulation On from 45 days post 12 month visit and on.

Group II

Sham
No Stimulation until 45 days post-implant. Stimulation On from 45 days post-implant and on.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 11 locations

Suspended

Arizona Health Sciences Center (University of Arizona)

Tucson, United StatesSee the location
Suspended

The Department of Urology, Stanford University Medical Center

Stanford, United States
Suspended

Milestone Medical Research

Englewood, United States
Suspended

Bladder Control Center of Norwalk

Norwalk, United States
Completed11 Study Centers